ArticleBMC pulmonary medicine2025

Younger severe asthma patients with interleukin 4 (CC variant) and dupilumab treatment are more likely to achieve clinical remission.

Mona Al-Ahmad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.